The EMA assessment of encorafenib in combination with cetuximab for the treatment of adult patients with metastatic colorectal carcinoma harbouring the BRAFV600E mutation who have received prior therapy
| Autor: | Trullas, A., Delgado, J., Koenig, J., Fuerstenau, U., Dedorath, J., Hausmann, S., Stock, T., Enzmann, H., Pignatti, F. |
|---|---|
| Zdroj: | In ESMO Open February 2021 6(1) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|